Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Dorenbaum

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Neurology. Clinical Practice|January 17, 2024
Characterization of Fatigue in Primary Mitochondrial Myopathies: Findings From a Qualitative Interview StudyAmel Karaa, Nathan Johnson, Ian Clarkson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthmaAllan T Luskin, Bradley E Chipps, Lawrence Rasouliyan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohortWilliam J Calhoun, Tmirah Haselkorn, David R Mink, et al.
JIMD Reports|February 23, 2013
Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?Christineh N Sarkissian, Alejandra Gamez, Patrick Scott, et al.
Cells|September 9, 2022
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular BioenergeticsOlivia M D'Annibale, Yu Leng Phua, Clinton Van't Land, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2013
Phenotypes determined by cluster analysis in severe or difficult-to-treat asthmaMichael Schatz, Jin-Wen Y Hsu, Robert S Zeiger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine doseMark Mirochnick, Alejandro Dorenbaum, Suzette Blanchard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected childrenPatricia Lester, Margaret Chesney, Molly Cooke, et al.
The Patient|July 16, 2017
Development of a Novel Tool to Assess the Impact of Itching in Pediatric CholestasisBinita M Kamath, Linda Abetz-Webb, Ciara Kennedy, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Neurology. Clinical Practice|January 17, 2024
Characterization of Fatigue in Primary Mitochondrial Myopathies: Findings From a Qualitative Interview StudyAmel Karaa, Nathan Johnson, Ian Clarkson, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 13, 2014
Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthmaAllan T Luskin, Bradley E Chipps, Lawrence Rasouliyan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Clinical burden and predictors of asthma exacerbations in patients on guideline-based steps 4-6 asthma therapy in the TENOR cohortWilliam J Calhoun, Tmirah Haselkorn, David R Mink, et al.
JIMD Reports|February 23, 2013
Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?Christineh N Sarkissian, Alejandra Gamez, Patrick Scott, et al.
Cells|September 9, 2022
Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular BioenergeticsOlivia M D'Annibale, Yu Leng Phua, Clinton Van't Land, et al.
The Journal of Allergy and Clinical Immunology|December 10, 2013
Phenotypes determined by cluster analysis in severe or difficult-to-treat asthmaMichael Schatz, Jin-Wen Y Hsu, Robert S Zeiger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine doseMark Mirochnick, Alejandro Dorenbaum, Suzette Blanchard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 20, 2002
When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected childrenPatricia Lester, Margaret Chesney, Molly Cooke, et al.
The Patient|July 16, 2017
Development of a Novel Tool to Assess the Impact of Itching in Pediatric CholestasisBinita M Kamath, Linda Abetz-Webb, Ciara Kennedy, et al.
Pageof 3